Peripheral Markers of Depression

Cites (457)

Items 201–400 of 451

1. Nitric oxide and major depression
   Ashish Dhir, S. K. Kulkarni · 2011 · Nitric Oxide
2. Α Review on the Acute Phase Response in Major Depression
   Maes, Michael · 1993 · Reviews in the Neurosciences
3. Blood microRNA changes in depressed patients during antidepressant treatment
   Bocchio-Chiavetto, Luisella, Maffioletti, Elisabetta, Bettinsoli, Paola, Giovannini, Caterina, Bignotti, Stefano, Tardito, Daniela, Corrada, Dario, Milanesi, Luciano, Gennarelli, Massimo · 2013 · European Neuropsychopharmacology
4. Raised Plasma Levels of Tumor Necrosis Factor α in Patients With Depression: Normalization During Electroconvulsive Therapy
   Hestad, Knut A., Tønseth, Sverre, Støen, Charlotte D., Ueland, Thor, Aukrust, Pål · 2003 · The Journal of ECT
5. Differential diagnosis of bipolar disorder and major depressive disorder
   Hirschfeld, R.M. · 2014 · Journal of Affective Disorders
6. The common inflammatory etiology of depression and cognitive impairment: a therapeutic target
   David J Allison, David S. Ditor · 2014 · Journal of Neuroinflammation
7. Oxidative Stress and Antioxidant Parameters in Patients With Major Depressive Disorder Compared to Healthy Controls Before and After Antidepressant Treatment
   Sara Jiménez‐Fernández, Manuel Gurpegui, Francisco Díaz-Atienza, Lucía Pérez-Costillas, Miriam Gerstenberg, Christoph Ulrich Correll · 2015 · The Journal of Clinical Psychiatry
8. MicroRNAs as biomarkers for CNS disease
   Pooja Rao, Eva Benito, André Fischer · 2013 · Frontiers in Molecular Neuroscience
9. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis Possible candidate genes
   David F. Horrobin, Crispin N. Bennett · 1999 · Prostaglandins Leukotrienes and Essential Fatty Acids
10. Depressive symptoms and metabolic syndrome: is inflammation the underlying link?
    Capuron, Lucile, Su, Shaoyong, Miller, Andrew H., Bremner, J. Douglas, Goldberg, Jack, Vogt, Gerald J., Maisano, Carisa, Jones, Linda, Murrah, Nancy V., Vaccarino, Viola · 2008 · Biological Psychiatry
11. Hypozincemia in depression
    Michael H. J. Maes, Patrick C. D’Haese, Simon Scharpé, Peter D'Hondt, Paul R. Cosyns, Marc E. De Broe · 1994 · Journal of Affective Disorders
12. Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis
    Sarah A. Hiles, Amanda Baker, Theo de Malmanche, John Attia · 2012 · Psychological Medicine
13. Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment
    Gałecki, Piotr, Szemraj, Janusz, Bieńkiewicz, Małgorzata, Florkowski, Antoni, Gałecka, Elżbieta · 2009 · Pharmacological Reports
14. Antidepressant therapies inhibit inflammation and microglial M1-polarization
    Kalkman, Hans O., Feuerbach, Dominik · 2016 · Pharmacology & Therapeutics
15. Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence.
    Matti Virkkunen, David A Goldman, D A Nielsen, M. Linnoila · 1995 · PubMed Central
16. Cytokines and serotonin transporter in patients with major depression
    Chiung-Wen Tsao, Yee-Shin Lin, Chwen-Cheng Chen, Chyi‐Huey Bai, Shin-Rung Wu · 2006 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
17. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women
    Çiğdem Aydemir, E. Yalcın, Sebahat Aksaray, Cebrail Kısa, Sema Gülen Yildirim, Tayfun I. Uzbay, Erol Göka · 2006 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
18. Polygenic interactions with environmental adversity in the aetiology of major depressive disorder
    Niamh Mullins, Robert A. Power, Helen Louise Fisher, Ken Benjamin Hanscombe, Jack Euesden, Raquel Iniesta, Douglas F. Levinson, Myrna M. Weissman, James B. Potash, Jianxin Shi et al. · 2015 · Psychological Medicine
19. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS‐damaged neoepitopes
    Michael H. J. Maes, Marta Kubera, Jean–Claude Leunis, M. Berk, M. Geffard, E. Bosmans · 2012 · Acta Psychiatrica Scandinavica
20. The 5-HT1A receptor in Major Depressive Disorder
    Joshua Kaufman, Christine DeLorenzo, Sunia Choudhury, Ramin V. Parsey · 2016 · European Neuropsychopharmacology
21. Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial
    Jha, Manish K., Minhajuddin, Abu, Gadad, Bharathi S., Greer, Tracy, Grannemann, Bruce, Soyombo, Abigail, Mayes, Taryn L., Rush, A. John, Trivedi, Madhukar H. · 2017 · Psychoneuroendocrinology
22. Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder
    Behr, Guilherme A., Moreira, José C. F., Frey, Benicio N. · 2012 · Oxidative Medicine and Cellular Longevity
23. Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks
    Gadad, Bharathi S., Jha, Manish K., Czysz, Andrew, Furman, Jennifer L., Mayes, Taryn L., Emslie, Michael P., Trivedi, Madhukar H. · 2018 · Journal of Affective Disorders
24. Alterations of Serum Levels of BDNF-Related miRNAs in Patients with Depression
    Youjie Li, Mei Xu, Gao Zong-hua, Yaqi Wang, Zhen Yue, Yan-Xia Zhang, Xinxin Li, Can Martin Zhang, Shuyang Xie, Pingyu Wang · 2013 · PLoS ONE
25. Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
    Carvalho, André F., Solmi, Marco, Sanches, Marcos, Machado, Myrela O., Stubbs, Brendon, Ajnakina, Olesya, Sherman, Chelsea, Sun, Yue Ran, Liu, Celina S., Brunoni, Andre R. et al. · 2020 · Translational Psychiatry
26. Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women
    Joel W. Hughes, Lana L. Watkins, James A. Blumenthal, Cynthia M. Kuhn, Andrew Sherwood · 2004 · Journal of Psychosomatic Research
27. Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients
    Daniel Martins‐de‐Souza, Paul C. Guest, Laura Wiseman Harris, Natacha Vanattou‐Saïfoudine, Maree J. Webster, Hassan Rahmoune, Sabine Bahn · 2012 · Translational Psychiatry
28. Interface between hypothalamic‐pituitary‐adrenal axis and brain‐derived neurotrophic factor in depression
    Kunugi, Hiroshi, Hori, Hiroaki, Adachi, Naoki, Numakawa, Tadahiro · 2010 · Psychiatry and Clinical Neurosciences
29. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia
    Guey‐Mei Jow, Tsung‐Tsair Yang, Chun-Lan Chen · 2005 · Journal of Affective Disorders
30. Immune Disturbances during Major Depression: Upregulated Expression of Interleukin-2 Receptors
    Michael H. J. Maes, E. Bosmans, Eduard Suy, Carine Vandervorst, C. De Jonckheere, Jef Raus · 2008 · Neuropsychobiology
31. Smoking and Depression: An Examination of Mechanisms of Comorbidity
    Lisa Dierker, Shelli Avenevoli, Marilyn J. Stolar, Kathleen Ries Merikangas · 2002 · American Journal of Psychiatry
32. Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study
    Prins, Bram. P., Abbasi, Ali, Wong, Anson, Vaez, Ahmad, Nolte, Ilja, Franceschini, Nora, Stuart, Philip E., Guterriez Achury, Javier, Mistry, Vanisha, Bradfield, Jonathan P. et al. · 2016 · PLOS Medicine
33. Identification and Validation of Urinary Metabolite Biomarkers for Major Depressive Disorder
    Peng Zheng, Ying Wang, Liang Chen, Deyu Yang, Huaqing Meng, Dezhi Zhou, Jiaju Zhong, Yang Lei, Narayan D. Melgiri, Peng Xie · 2012 · Molecular & Cellular Proteomics
34. Antioxidative enzymes and increased oxidative stress in depressive women
    Kodydková, Jana, Vávrová, Lucie, Zeman, Miroslav, Jirák, Roman, Macášek, Jaroslav, Staňková, Barbora, Tvrzická, Eva, Žák, Aleš · 2009 · Clinical Biochemistry
35. Chronic interpersonal stress predicts activation of pro- and anti-inflammatory signaling pathways 6 months later
    Miller, Gregory E., Rohleder, Nicolas, Cole, Steve W. · 2009 · Psychosomatic Medicine
36. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls
    Cai Song, Timothy G. Dinan, Brian E. Leonard · 1994 · Journal of Affective Disorders
37. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder
    Wendy E Chrapko, Paul Jurasz, Marek Witold Radomski, Nathalie Lara, Stephen L. Archer, Jean‐Michel Le Mellédo · 2004 · Biological Psychiatry
38. Inflammatory theory of depression
    Gałecki, Piotr, Talarowska, Monika · 2018 · Psychiatria Polska
39. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
    Tiao-Lai Huang, Chien-Te Lee, Yu-li Liu · 2008 · Journal of Psychiatric Research
40. A meta-analysis of chemokines in major depression
    Eyre, Harris A., Air, Tracy, Pradhan, Alyssa, Johnston, James, Lavretsky, Helen, Stuart, Michael J., Baune, Bernhard T. · 2016 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
41. Vulnerability to Depression: From Brain Neuroplasticity to Identification of Biomarkers
    A. Blugeot, C. Rivat, E. Bouvier, J. Molet, Amandine Mouchard, B. Zeau, C. Bernard, J. Benoliel, C. Becker · 2011 · Journal of Neuroscience
42. Integrating NIMH Research Domain Criteria (RDoC) into depression research
    Mary L. Woody, Brandon E. Gibb · 2015 · Current Opinion in Psychology
43. Antioxidants as Antidepressants
    Giovanni Scapagnini, Sergio Davinelli, Filippo Drago, Antonino DE LORENZO, Giovannangelo Oriani · 2012 · CNS Drugs
44. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: The prospective Sydney Memory and Aging Study
    B. Baune, Evelyn Smith, Simone Reppermund, Tracy Air, Katherine Samaras, Ora Lux, Henry Brodaty, Perminder Singh Sachdev, Julian Norman Trollor · 2012 · Psychoneuroendocrinology
45. Plasma <scp>L</scp> -Tryptophan Concentration in Major Depressive Disorder: New Data and Meta-Analysis
    Ogawa, Shintaro, Fujii, Takashi, Koga, Norie, Hori, Hiroaki, Teraishi, Toshiya, Hattori, Kotaro, Noda, Takamasa, Higuchi, Teruhiko, Motohashi, Nobutaka, Kunugi, Hiroshi · 2014 · The Journal of Clinical Psychiatry
46. Role of Adiposity-Driven Inflammation in Depressive Morbidity
    Capuron, Lucile, Lasselin, Julie, Castanon, Nathalie · 2017 · Neuropsychopharmacology
47. The relevance of oxidative stress status in first episode and recurrent depression
    Stefanescu, Cristinel, Ciobica, Alin · 2012 · Journal of Affective Disorders
48. A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: Do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression?
    Walker, Frederick Rohan · 2013 · Neuropharmacology
49. Activation of cell-mediated immunity in depression: Association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression
    Michael H. J. Maes, Ivana Mihaylova, Marta Kubera, Karl Ringel · 2011 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
50. Depression research: where are we now?
    Saebom Lee, Jaehoon Jeong, Yongdo Kwak, Sang Ki Park · 2010 · Molecular Brain
51. Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system
    Carvalho, L.A., Torre, J.P., Papadopoulos, A.S., Poon, L., Juruena, M.F., Markopoulou, K., Cleare, A.J., Pariante, C.M. · 2013 · Journal of Affective Disorders
52. Total antioxidant capacity and total oxidant status in patients with major depression: Impact of antidepressant treatment
    Cumurcu, Birgul Elbozan, Ozyurt, Huseyin, Etikan, Ilker, Demir, Suleyman, Karlidag, Rifat · 2009 · Psychiatry and Clinical Neurosciences
53. Spatial and temporal expression of short, long/medium, or both opsins in human fetal cones
    Ming Xiao, Anita E. Hendrickson · 2000 · The Journal of Comparative Neurology
54. Regulation of Cellular Plasticity Cascades in the Pathophysiology and Treatment of Mood Disorders
    Carlos A. Zarate, Jing Du, Jorge A. Quiroz, NEIL A. GRAY, Kirk D. Denicoff, Jaskaran Singh, Dennis S. Charney, Husseini K. Manji · 2003 · Annals of the New York Academy of Sciences
55. Plasma Phosphatidylcholine and Sphingomyelin Concentrations Are Associated with Depression and Anxiety Symptoms in a Dutch Family-Based Lipidomics Study
    Demirkan, Ayşe, Isaacs, Aaron, Ugocsai, Peter, Liebisch, Gerhard, Struchalin, Maksim, Rudan, Igor, Wilson, James F., Pramstaller, Peter P., Gyllensten, Ulf, Campbell, Harry et al. · 2013 · Journal of Psychiatric Research
56. Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men
    Austin, M C, Janosky, J E, Murphy, H A · 2003 · Molecular Psychiatry
57. Serotonin-1A receptor alterations in depression: a meta-analysis of molecular imaging studies
    Wang, Ling, Zhou, Chanjuan, Zhu, Dan, Wang, Xinfa, Fang, Liang, Zhong, Jiaju, Mao, Qiang, Sun, Lu, Gong, Xue, Xia, Jinjun et al. · 2016 · BMC Psychiatry
58. Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis
    Brisa Simões Fernandes, M Berk, Christoph W. Turck, Johann Steiner, C-A Gonçalves · 2013 · Molecular Psychiatry
59. Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome.
    Michael H. J. Maes, Ivanka Mihaylova, Marta Kubera, Marc Uytterhoeven, Nicolas Vrydags, Eugène Bosmans · 2009 · PubMed
60. Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice
    Sook-Eun Park, Robert Dantzer, Keith W. Kelley, Robert H. McCusker · 2011 · Journal of Neuroinflammation
61. Depression and C-Reactive Protein: Population-Based Health 2000 Study
    Elovainio, Marko, Aalto, Anna-Mari, Kivimäki, Mika, Pirkola, Sami, Sundvall, Jouko, Lönnqvist, Jouko, Reunanen, Antti · 2009 · Psychosomatic Medicine
62. Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases
    Valerio Chiurchiù, Antonio Orlacchio, Mauro Maccarrone · 2015 · Oxidative Medicine and Cellular Longevity
63. The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression
    Küçükibrahimoğlu, Esra, Saygın, Melek Z., Çalışkan, Mecit, Kaplan, Okan K., Ünsal, Cüneyt, Gören, M. Zafer · 2009 · European Journal of Clinical Pharmacology
64. Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression
    Alexander S. Korb, Aimee M. Hunter, Ian A. Cook, Andrew F. Leuchter · 2009 · Clinical Neurophysiology
65. Suppression of Cell Proliferation by Interferon-Alpha through Interleukin-1 Production in Adult Rat Dentate Gyrus
    Kaneko, Naoko, Kudo, Koutaro, Mabuchi, Tadashi, Takemoto, Keiko, Fujimaki, Koichiro, Wati, Henny, Iguchi, Hironobu, Tezuka, Hideo, Kanba, Shigenobu · 2006 · Neuropsychopharmacology
66. The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease
    Tim Vanuytsel, Séverine Vermeire, Isabelle Cleynen · 2013 · Tissue Barriers
67. Serum markers support disease-specific glial pathology in major depression
    Schroeter, Matthias L., Abdul-Khaliq, Hashim, Krebs, Michael, Diefenbacher, Albert, Blasig, Ingolf E. · 2008 · Journal of Affective Disorders
68. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: A 24-week follow-up study
    Kotan, Vahap Ozan, Sarandol, Emre, Kirhan, Emine, Ozkaya, Guven, Kirli, Selcuk · 2011 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
69. Depression and depressive symptoms in rheumatoid arthritis patients: an analysis of their occurrence and determinants
    Ahmed M. Abdel-Nasser · 1998 · British journal of rheumatology
70. Plasma lipidomics reveals potential lipid markers of major depressive disorder
    Liu, Xinyu, Li, Jia, Zheng, Peng, Zhao, Xinjie, Zhou, Chanjuan, Hu, Chunxiu, Hou, Xiaoli, Wang, Haiyang, Xie, Peng, Xu, Guowang · 2016 · Analytical and Bioanalytical Chemistry
71. Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications
    George Anderson, Michael H. J. Maes · 2014 · Current Pharmaceutical Design
72. Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression
    Rybka, Joanna, Kędziora-Kornatowska, Kornelia, Banaś-Leżańska, Patrycja, Majsterek, Ireneusz, Carvalho, Livia A., Cattaneo, Annamaria, Anacker, Christoph, Kędziora, Józef · 2013 · Free Radical Biology and Medicine
73. Links between circadian rhythms and psychiatric disease
    Karatsoreos, Ilia N. · 2014 · Frontiers in Behavioral Neuroscience
74. Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants
    Seung‐Yup Lee, Soo-Jung Lee, Changsu Han, Ashwin A. Patkar, Prakash S. Masand, Chi‐Un Pae · 2012 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
75. Serum lipid concentrations in patients with major depressive disorder
    Samuel Olusoji Olusi, Abdullahi Ali Fido · 1996 · Biological Psychiatry
76. Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: Markers that further explain the higher incidence of neurodegeneration and coronary artery disease
    Michael H. J. Maes, Ivanka Mihaylova, Marta Kubera, Marc Uytterhoeven, Nicolas Vrydags, Eugène Bosmans · 2010 · Journal of Affective Disorders
77. Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder
    Amelia Versace, Ana C. Andreazza, Lionel Trevor Young, Jay C.J. Fournier, Jorge Almeida, Richelle S. Stiffler, Jeanette Lockovich, Haris A. Aslam, Myrna Pollock, H Park et al. · 2013 · Molecular Psychiatry
78. Different immune patterns in melancholic and non-melancholic major depression
    Matthias Rothermundt, Volker Arolt, Jan Fenker, Heike Gutbrodt, Marion Peters, Holger Kirchner · 2001 · European Archives of Psychiatry and Clinical Neuroscience
79. Are Cholesterol and Depression Inversely Related? A Meta-analysis of the Association Between Two Cardiac Risk Factors
    Ju Young Shin, Jerry M. Suls, René Martin · 2008 · Annals of Behavioral Medicine
80. The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder
    Gałecki, Piotr, Gałecka, Elżbieta, Maes, Michael, Chamielec, Marcelina, Orzechowska, Agata, Bobińska, Kinga, Lewiński, Andrzej, Szemraj, Janusz · 2012 · Journal of Affective Disorders
81. Targeting classical IL-6 signalling or IL-6<i>trans</i>-signalling in depression?
    Maes, Michael, Anderson, George, Kubera, Marta, Berk, Michael · 2014 · Expert Opinion on Therapeutic Targets
82. A preliminary metabolomic analysis of older adults with and without depression
    Paige, Lisa A., Mitchell, Matthew W., Krishnan, K. Ranga R., Kaddurah‐Daouk, Rima, Steffens, David C. · 2007 · International Journal of Geriatric Psychiatry
83. Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression
    Agnieszka Szuster‐Ciesielska, Maria Słotwińska, Anna Stachura, Halina Marmurowska-Michałowska, Halina Dubas-Ślemp, Agnieszka A. Bojarska-Junak, Martyna Kandefer‐Szerszeń · 2007 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
84. Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank: Figure 1.
    Elizabeth Scarr, Mark John Millan, Sabine Bahn, Alessandro Bertolino, Christoph W. Turck, Shitij Kapur, Hans‐Jürgen Möller, Brian Dean · 2015 · The International Journal of Neuropsychopharmacology
85. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.
    Michael H. J. Maes, Ivanka Mihaylova, Marta Kubera, Marc Uytterhoeven, Nicolas Vrydags, Eugène Bosmans · 2009 · PubMed
86. HPA axis and sleep: Identifying subtypes of major depression
    Irina A. Antonijevic, Irina A. Antonijevic · 2008 · Stress
87. Molecular biomarkers of depression
    Anand Gururajan, Gerard A. Clarke, Timothy G. Dinan, John F. Cryan · 2016 · Neuroscience & Biobehavioral Reviews
88. Tobacco smoking as a risk factor for depression. A 26-year population-based follow-up study
    Trine Flensborg‐Madsen, Mikael Bay von Scholten, Esben Meulengracht Flachs, Erik Lykke Mortensen, Eva Prescott, Janne Schurmann Tolstrup · 2010 · Journal of Psychiatric Research
89. The Fibroblast Growth Factor System and Mood Disorders
    Turner, Cortney A., Akil, Huda, Watson, Stanley J., Evans, Simon J. · 2006 · Biological Psychiatry
90. Inflammatory markers and cognitive function in middle-aged adults: The Whitehall II study
    David Gimeno, Michael Gideon Marmot, Archana Singh‐Manoux · 2008 · Psychoneuroendocrinology
91. Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept
    Rima F Kaddurah-Daouk, S. H. Boyle, Wayne R. Matson, S Sharma, Samantha A. Matson, Hongjie Zhu, Mikhail B. Bogdanov, Erik Churchill, Ranga Rama Krishnan, Augustus John Rush et al. · 2011 · Translational Psychiatry
92. The ratio of cortisol/DHEA in treatment resistant depression
    Kalypso Markopoulou, Andrew S. Papadopoulos, Mário F. Juruena, Lucia Poon, Carmine Maria Pariante, Anthony James Cleare · 2008 · Psychoneuroendocrinology
93. Cytokine‐induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN‐γ and TNF‐α on apoptosis
    Mieke Buntinx, Marjan Moreels, Frank Vandenabeele, Ivo Lambrichts, Jef Raus, Paul Steels, Piet Stinissen, Marcel M. Ameloot · 2004 · Journal of Neuroscience Research
94. The association between anxiety and C-reactive protein (CRP) levels: results from the Northern Finland 1966 Birth Cohort Study
    Liukkonen, T., Räsänen, P., Jokelainen, J., Leinonen, M., Järvelin, M.-R., Meyer-Rochow, V.B., Timonen, M. · 2011 · European Psychiatry
95. Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression — No influence of celecoxib treatment
    Richard Musil, Markus Schwarz, Michael J Riedel, Sandra Dehning, Anja Cerovecki, Ilja Spellmann, Volker Arolt, Norbert Müller · 2011 · Journal of Affective Disorders
96. Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients
    Gałecki, Piotr, Szemraj, Janusz, Bieńkiewicz, Małgorzata, Zboralski, Krzysztof, Gałecka, Elżbieta · 2009 · Human Psychopharmacology: Clinical and Experimental
97. Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise
    Duman, Catharine H., Schlesinger, Lee, Terwilliger, Rosemarie, Russell, David S., Newton, Samuel S., Duman, Ronald S. · 2009 · Behavioural Brain Research
98. Prevalence and Treatment Outcome in Anxious Versus Nonanxious Depression
    Katja Wiethoff, Michael Bauer, Thomas C. Baghai, Hans‐Jürgen Möller, Robert Fisher, Dorothea Lisa Hollinde, Julia Kiermeir, Iris Hauth, Gerd Laux, Joachim Cordes et al. · 2010 · The Journal of Clinical Psychiatry
99. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases
    Praticò, Domenico, Rokach, Joshua, Lawson, John, FitzGerald, Garret A. · 2004 · Chemistry and Physics of Lipids
100. Treatment response and cognitive impairment in major depression: Association with C-reactive protein
     Chang, Hui Hua, Lee, I Hui, Gean, Po Wu, Lee, Sheng-Yu, Chi, Mei Hung, Yang, Yen Kuang, Lu, Ru-Band, Chen, Po See · 2012 · Brain, Behavior, and Immunity
101. Depression and oxidative damage to lipids
     Yager, Sarah, Forlenza, Michael J., Miller, Gregory E. · 2010 · Psychoneuroendocrinology
102. IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology
     Michael H. J. Maes, Ivana Mihaylova, Marta Kubera, Jean–Claude Leunis, M. Geffard · 2011 · Journal of Affective Disorders
103. The role of lipid biomarkers in major depression
     Parekh, Amy, Smeeth, Demelza, Milner, Yasmin, Thuret, Sandrine · 2017 · Healthcare
104. Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women
     J HUGHES, Lana L. Watkins, James A. Blumenthal · 2004 · Journal of Psychosomatic Research
105. Increased plasma levels of 8-iso-PGF2α and IL-6 in an elderly population with depression
     Dimopoulos, Nikolaos, Piperi, Christina, Psarra, Vassiliki, Lea, Robert W., Kalofoutis, Anastasios · 2008 · Psychiatry Research
106. Increased autoimmune activity against 5-HT: A key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression
     Maes, Michael, Ringel, Karl, Kubera, Marta, Berk, Michael, Rybakowski, Janusz · 2012 · Journal of Affective Disorders
107. Biochemical markers subtyping major depressive disorder
     Hiroshi Kunugi, Hiroaki Hori, Shintaro Ogawa · 2015 · Psychiatry and Clinical Neurosciences
108. Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression
     Jantien P. Brouwer, Bente C. Appelhof, Elisabeth F. C. van Rossum, Jan Willem Koper, Eric Fliers, Jochanan Huyser, Aart H. Schene, Jan G.P. Tijssen, Richard van Dyck, Steven W. J. Lamberts et al. · 2006 · Psychoneuroendocrinology
109. Structural and functional models of depression: from sub‐types to substrates
     Gin Singh Malhi, Gordon Barraclough Parker, J. Greenwood · 2005 · Acta Psychiatrica Scandinavica
110. Urinary biomarker panel for diagnosing patients with depression and anxiety disorders
     Jianjun Chen, Shunjie Bai, Wenwen Li, Chanjuan Zhou, Peng Zheng, Liang Fang, Haiyang Wang, Yiyun Liu, Peng Xie · 2018 · Translational Psychiatry
111. Gestational stress induces depressive-like and anxiety-like phenotypes through epigenetic regulation of BDNF expression in offspring hippocampus
     Zheng, Yu, Fan, Weidong, Zhang, Xianquan, Dong, Erbo · 2016 · Epigenetics
112. Increased plasma nitric oxide level associated with suicide attempt in depressive patients
     Yong‐Ku Kim, Jong‐Woo Paik, Sung-Woo Lee, Dokyung Yoon, Changsu Han, Bun-Hee Lee · 2006 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
113. VEGF and depression: A comprehensive assessment of clinical data
     Clark-Raymond, Anne, Halaris, Angelos · 2013 · Journal of Psychiatric Research
114. Ghrelin in psychiatric disorders – A review
     Dirk Alexander Wittekind, Michael Kluge · 2014 · Psychoneuroendocrinology
115. Inflammation, Serotonin and Major Depression
     Mario Catena-Dell’Osso, Francesco Rotella, Adriana Dell’Osso, Andrea M. Fagiolini, Donatella Marazziti · 2013 · Current Drug Targets
116. Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses
     Marie‐Claude Audet, Hymie Anisman · 2013 · Frontiers in Cellular Neuroscience
117. Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review
     Kellie MacDonald, Ankur Krishnan, Emily Cervenka, Grace Hu, Elena Guadagno, Yannis J Trakadis · 2018 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
118. A Novel Urinary Metabolite Signature for Diagnosing Major Depressive Disorder
     Peng Zheng, Jianjun Chen, Ting Huang, Mingju Wang, Ying Wang, Mei-Xue Dong, Yuan-jun Huang, Lin-ke Zhou, Peng Xie · 2013 · Journal of Proteome Research
119. Melancholia and atypical depression in the Zurich study: epidemiology, clinical characteristics, course, comorbidity and personality
     Jules Angst, Alex Gamma, Franco Benazzi, Vladeta Ajdacic‐Gross, Wulf Rössler A · 2007 · Acta Psychiatrica Scandinavica
120. Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder
     Jun‐ichi Iga, Shuichi Ueno, Ken Yamauchi, Shusuke Numata, Sumiko Shibuya‐Tayoshi, Sawako Kinouchi, Masahito Nakataki, Hongwei Song, Kazuhiko Hokoishi, Hirotaka Tanabe et al. · 2006 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
121. Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients
     Stelzhammer, Viktoria, Haenisch, Frieder, Chan, Man K., Cooper, Jason D., Steiner, Johann, Steeb, Hannah, Martins-de-Souza, Daniel, Rahmoune, Hassan, Guest, Paul C., Bahn, Sabine · 2014 · The International Journal of Neuropsychopharmacology
122. Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression
     KATHLEEN A. PAJER, Brian M. Andrus, William P Gardner, Andrea Lourie, Brandon Strange, John V. Campo, Jeffrey A. Bridge, Katherine D. Blizinsky, K Dennis, Peter T. Vedell et al. · 2012 · Translational Psychiatry
123. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts
     Sowa-Kućma, Magdalena, Styczeń, Krzysztof, Siwek, Marcin, Misztak, Paulina, Nowak, Rafał J., Dudek, Dominika, Rybakowski, Janusz K., Nowak, Gabriel, Maes, Michael · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
124. Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment
     Abdullah Önder Barim, Süleyman Aydın, Ramis Çolak, Ersel Dağ, Omer Deniz, İbrahim Şahin · 2009 · Clinical Biochemistry
125. On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review
     Pinto, Jairo Vinícius, Moulin, Thiago C., Amaral, Olavo B. · 2017 · Neuroscience &amp; Biobehavioral Reviews
126. The role of adipokines in the rapid antidepressant effects of ketamine
     Machado-Vieira, R, Gold, P W, Luckenbaugh, D A, Ballard, E D, Richards, E M, Henter, I D, De Sousa, R T, Niciu, M J, Yuan, P, Zarate, C A · 2017 · Molecular Psychiatry
127. Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo
     Rima F Kaddurah-Daouk, Mikhail B. Bogdanov, William R. Wikoff, Hongjie Zhu, S. H. Boyle, Erik Churchill, Z Wang, Augustus John Rush, Ranga Rama Krishnan, Eve H. Pickering et al. · 2013 · Translational Psychiatry
128. The effect of raising and lowering tryptophan levels on human mood and social behaviour
     Simon N. Young · 2013 · Philosophical Transactions of the Royal Society B Biological Sciences
129. Melancholic and atypical major depression—Connection between cytokines, psychopathology and treatment
     Dunjic-Kostic, Bojana, Ivkovic, Maja, Radonjic, Nevena V., Petronijevic, Natasa D., Pantovic, Maja, Damjanovic, Aleksandar, Poznanovic, Sanja Totic, Jovanovic, Aleksandar, Nikolic, Tanja, Jasovic-Gasic, Miroslava · 2013 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
130. Is platelet imipramine binding reduced in depression? A meta-analysis
     Peter M. Ellis, Clare E. Salmond · 1994 · Biological Psychiatry
131. Increased oxidative stress in patients with depression and its relationship to treatment
     Cecilia P. Chung, Dennis E. Schmidt, Charles Michael Stein, Jason D. Morrow, Ronald M. Salomon · 2012 · Psychiatry Research
132. BDNF blood levels after electroconvulsive therapy in patients with mood disorders: A systematic review and meta-analysis
     André R. Brunoni, Chris Baeken, Rodrigo Machado‐Vieira, Wagner F. Gattaz, Marie–Anne Vanderhasselt · 2014 · The World Journal of Biological Psychiatry
133. Review: the role of inflammation in depression.
     Amisha J. Patel · 2013 · PubMed
134. Epigenetic Modulation of BDNF Gene in Patients with Major Depressive Disorder
     Claudio D’Addario, Bernardo Maria Dell’Osso, Daniela Galimberti, Carlotta Palazzo, Beatrice Benatti, Andrea Di Francesco, Elio Angelo Scarpini, A. Carlo Altamura, Mauro Maccarrone · 2012 · Biological Psychiatry
135. Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder
     Daniel Martins‐de‐Souza · 2014 · Dialogues in Clinical Neuroscience
136. Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression
     Raoul Belzeaux-R, Christine Formisano‐Tréziny, Anderson Loundou, Laurent Boyer, Jean A. Gabert, Jean‐Claude Samuelian, Francois pierre Feron, Jean Naudin, El Chérif Ibrahim · 2010 · Journal of Psychiatric Research
137. A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates
     Brand, Sarel, Moller, Marisa, Harvey, Brian · 2015 · Current Neuropharmacology
138. Increase in Plasma Proinflammatory Cytokines After Electroconvulsive Therapy in Patients With Depressive Disorder
     Kai A. Lehtimäki, Tapani Keränen, Martti Huuhka, Johanna Palmio, Mikko Hurme, Esa V. J. Leinonen, Jukka Peltola · 2008 · Journal of Ect
139. Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors
     L Conboy, Emilio Varea, J E Castro, Hajer Ouertatani-Sakouhi, Thierry Calandra, Hilal Ahmed Lashuel, Carmen Sandi · 2010 · Molecular Psychiatry
140. The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders - relation to drug treatment
     Norbert Müller, Aye-Mu Myint, Markus Schwarz · 2009 · Dialogues in Clinical Neuroscience
141. Dimensionality and the category of major depressive episode
     Gavin Andrews, Traolach Sean Brugha, Michael E. Thase, Farifteh Firoozmand Duffy, Paola Rucci, Tim N Slade · 2007 · International Journal of Methods in Psychiatric Research
142. C-reactive protein is elevated in atypical but not nonatypical depression: Data from the National Health and Nutrition Examination Survey (NHANES) 1999–2004
     Hickman, Ruth J., Khambaty, Tasneem, Stewart, Jesse C. · 2014 · Journal of Behavioral Medicine
143. Rumination and Impaired Cortisol Recovery Following a Social Stressor in Adolescent Depression
     Jeremy Gordon Stewart, Raegan Mazurka, L. Bond, Katherine E. Wynne‐Edwards, Kate Leslie Harkness · 2013 · Research on Child and Adolescent Psychopathology
144. Nitric Oxide-Directed Synaptic Remodeling in the Adult Mammal CNS
     Carmen R. Sunico, Federico Portillo, David González‐Forero, Bernardo Moreno‐López · 2005 · Journal of Neuroscience
145. Subclinical hypothyroidism, mood, and cognition in older adults: a review
     Russell T. Joffe, Elizabeth N. Pearce, James V. Hennessey, Joseph J. Ryan, Robert A. Stern · 2012 · International Journal of Geriatric Psychiatry
146. Behavioral and psychological effects of immune activation
     Raz Yirmiya · 1997 · Current Opinion in Psychiatry
147. Serum proteomic profiles of depressive subtypes
     Femke Lamers, Mariska Bot, Rick Jansen, Man K. Chan, Jason D. Cooper, Sabine Bahn, Brenda W.J.H. Penninx · 2016 · Translational Psychiatry
148. Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia
     Magdalena Sowa-Kućma, Krzysztof Styczeń, Marcin Siwek, Paulina Misztak, Rafał J. Nowak, Dominika Dudek, JANUSZ K. RYBAKOWSKI, Gabriel Nowak, Michael H. J. Maes · 2017 · Neurotoxicity Research
149. Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: Implications for the pathways to chronic depression and neuroprogression
     Michael H. J. Maes, Marta Kubera, Ivana Mihaylova, M. Geffard, Piotr Gałecki, Jean-Clude Leunis, Michael Berk · 2012 · Journal of Affective Disorders
150. Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis
     Andre Ferrer Carvalho, Cristiano André Köhler, Roger S. McIntyre, Christian Knöchel, André R. Brunoni, Michael E. Thase, João Quevedo, Brisa Simões Fernandes, Michael Berk · 2015 · Psychoneuroendocrinology
151. The current status of the platelet 5-HT2A receptor in depression
     Scott D. Mendelson · 2000 · Journal of Affective Disorders
152. Clinical Subtypes of Depression Are Associated with Specific Metabolic Parameters and Circadian Endocrine Profiles in Women: The Power Study
     Giovanni Cizza, Donna S. Ronsaville, Hayley K. Kleitz‐Nelson, Farideh Eskandari, Sejal Mistry, Sara Torvik, Nina Sonbolian, James C. Reynolds, Marc R. Blackman, Philip W. Gold et al. · 2012 · PLoS ONE
153. Clinical Patterns and Treatment Outcome in Patients with Melancholic, Atypical and Non-Melancholic Depressions
     Margalida Gili, Miquel Roca, Sílvia Armengol, David Asensio, Javier García‐Campayo, Gordon Barraclough Parker · 2012 · PLoS ONE
154. Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy
     Redei, E E, Andrus, B M, Kwasny, M J, Seok, J, Cai, X, Ho, J, Mohr, D C · 2014 · Translational Psychiatry
155. Peripheral Biomarkers Revisited: Integrative Profiling of Peripheral Samples for Psychiatric Research
     Akiko Hayashi‐Takagi, Marquis P. Vawter, Kazuya Iwamoto · 2013 · Biological Psychiatry
156. The effect of stress on the dexamethasone suppression test
     Dominique L.S. Ceulemans, Herman G.M. Westenberg, Herman M. van Praag · 1985 · Psychiatry Research
157. Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression
     Rocco Hoekstra, Walter W. van den Broek, Durk Fekkes, Jan A Bruijn, Paul G.H. Mulder, L. Pepplinkhuizen · 2001 · Psychiatry Research
158. Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
     Yang Du, Huantong Wu, Xiao‐Yan Qin, Chang Qing Cao, Yi Liu, Zong-Ze Cao, Yong Cheng · 2018 · Journal of Molecular Neuroscience
159. Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response
     Michael H. J. Maes, Robert M. Verkerk, Eric Vandoolaeghe, Fran Van Hunsel, Hugo M. Neels, Annick Wauters, Paul Demedts, Simon Scharpé · 1997 · European Archives of Psychiatry and Clinical Neuroscience
160. Restoring melancholia in the classification of mood disorders
     Michael Alan Taylor, Max Fink · 2007 · Journal of Affective Disorders
161. The association between serum levels of neopterin and number of depressive episodes of major depression
     Cemil Çelik, Murat Erdem, Tuncer Çaycı, B. Handan Özdemir, Emin Özgür Akgül, Yasemin Gülcan Kurt, Halıl Yaman, Mehmet Isıntas, Fuat Özgen, Aytekin Özşahin · 2010 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
162. The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting
     Francesco Benedetti, Cristina Colombo, Adele Pirovano, Elena Marino, Enrico Smeraldi · 2008 · Psychopharmacology
163. Biomarkers for Depression: Recent Insights, Current Challenges and Future Prospects
     Rebecca Strawbridge, Allan Hunter Young, Anthony James Cleare · 2018 · FOCUS The Journal of Lifelong Learning in Psychiatry
164. Systemic oxidatively generated DNA/RNA damage in clinical depression: associations to symptom severity and response to electroconvulsive therapy
     Jorgensen, Anders, Krogh, Jesper, Miskowiak, Kamilla, Bolwig, Tom G., Kessing, Lars V., Fink-Jensen, Anders, Nordentoft, Merete, Henriksen, Trine, Weimann, Allan, Poulsen, Henrik E. et al. · 2013 · Journal of Affective Disorders
165. Low 24-Hour Adiponectin and High Nocturnal Leptin Concentrations in a Case-Control Study of Community-Dwelling Premenopausal Women With Major Depressive Disorder: The Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) Study
     Cizza, Giovanni, Nguyen, Vi T., Eskandari, Farideh, Duan, Zhigang, Wright, Elizabeth C., Reynolds, James C., Ahima, Rexford S., Blackman, Marc R., POWER Study Group · 2010 · The Journal of Clinical Psychiatry
166. Anterior cingulate cortex and cerebellar hemisphere neurometabolite changes in depression treatment: A 1H magnetic resonance spectroscopy study
     Liping Chen, Haiyang Dai, Zhuozhi Dai, XU Chong-tao, Renhua Wu · 2014 · Psychiatry and Clinical Neurosciences
167. The Expression of VGF is Reduced in Leukocytes of Depressed Patients and it is Restored by Effective Antidepressant Treatment
     Annamaria Cattaneo, Antonella Sesta, Francesca Calabrese, Gabriela Nielsen, Marco Andrea Riva, Massimo Gennarelli · 2010 · Neuropsychopharmacology
168. Tryptophan metabolism in depression
     G. Curzon, P. K. Bridges · 1970 · Journal of Neurology Neurosurgery & Psychiatry
169. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression
     Oliver Ambrée, Veerle Bergink, Laura Grosse, Judith Alferink, Hemmo A. Drexhage, Matthias Rothermundt, Volker Arolt, Tom K. Birkenhäger · 2015 · The International Journal of Neuropsychopharmacology
170. Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder
     Bashkim Kadriu, Philip W. Gold, David A. Luckenbaugh, Marc S. Lener, Elizabeth D. Ballard, Mark J. Niciu, Ioline D. Henter, Lawrence T. Park, R T De Sousa, P Yuan et al. · 2017 · Molecular Psychiatry
171. Major depression during interferon-α treatment: vulnerability and prevention
     Francis E. Lotrich · 2009 · Dialogues in Clinical Neuroscience
172. Antidepressants and the placebo response
     Irving Kirsch · 2009 · Epidemiology and Psychiatric Sciences
173. The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients
     Jean‐Michel Aubry, Nicola Gervasoni, Christian Osiek, Guillaume Perret, Michel Florian Rossier, Gilles Bertschy, Guido Bondolfi · 2006 · Journal of Psychiatric Research
174. A meta-analysis of lipid peroxidation markers in major depression
     Krista L. Lanctôt, Graham Mazereeuw, Nathan Herrmann, Ana C. Andreazza, Maisha M. Khan · 2015 · Neuropsychiatric Disease and Treatment
175. Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression.
     Michael H. J. Maes, Ivanka Mihaylova, Jean–Claude Leunis · 2007 · PubMed
176. Metabolomic Differences in Heart Failure Patients With and Without Major Depression
     Steffens, David C., Wei Jiang, Krishnan, K. Ranga R., Karoly, Edward D., Mitchell, Matthew W., O'Connor, Christopher M., Kaddurah-Daouk, Rima · 2010 · Journal of Geriatric Psychiatry and Neurology
177. The serum zinc concentration as a potential biological marker in patients with major depressive disorder
     Krzysztof Styczeń, Magdalena Sowa-Kućma, Marcin Siwek, Dominika Dudek, Witold Reczyński, Bernadeta Szewczyk, Paulina Misztak, Roman Topór‐Mądry, Włodzimierz Opoka, Gabriel Nowak · 2016 · Metabolic Brain Disease
178. Neurodevelopmental theory of depression
     Piotr Gałecki, Monika Ewa Talarowska · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
179. Polymorphisms in <i>BDNF</i> (Val66Met) and <i>5-HTTLPR</i>, morning cortisol and subsequent depression in at-risk adolescents
     Goodyer, Ian M., Croudace, Tim, Dudbridge, Frank, Ban, Maria, Herbert, Joe · 2010 · British Journal of Psychiatry
180. Metabolic Syndrome and Onset of Depressive Symptoms in the Elderly
     Tasnime Nassime Akbaraly, Marie‐Laure Ancelin, Isabelle Jaussent, Craig William Ritchie, Pascale Barberger‐Gateau, Carole Dufouil, Mika Kivimaki B, Claudine Berr, Karen A. Ritchie · 2011 · Diabetes Care
181. KYNURENINE METABOLITES AND INFLAMMATION MARKERS IN DEPRESSED PATIENTS TREATED WITH FLUOXETINE OR COUNSELLING
     Gillian Mackay, Caroline M. Forrest, J A Christofides, Michala A Bridel, Susan L. Mitchell, Richard Cowlard, Trevor W. Stone, Lynda Gail Darlington · 2008 · Clinical and Experimental Pharmacology and Physiology
182. Impaired natural killer cell activity among depressed patients
     Michael R. Irwin, J. Christian Gillin · 1987 · Psychiatry Research
183. Ozone exposure of Flinders Sensitive Line rats is a rodent translational model of neurobiological oxidative stress with relevance for depression and antidepressant response
     Mmalebuso L. Mokoena, Brian Herbert Harvey, Francois P. Viljoen, Susanna M. Ellis, Christiaan Beyers Brink · 2015 · Psychopharmacology
184. Role of cytokines in atypical depression
     Yoon, Ho-Kyoung, Kim, Yong-Ku, Lee, Heon-Jeong, Kwon, Do-Young, Kim, Leen · 2012 · Nordic Journal of Psychiatry
185. Associations of serum cytokine receptor levels with melancholia, staging of illness, depressive and manic phases, and severity of depression in bipolar disorder.
     Siwek, Marcin, Sowa-Kućma, Magdalena, Styczeń, Krzysztof, Misztak, Paulina, Nowak, Rafał J., Szewczyk, Bernadeta, Dudek, Dominika, Rybakowski, Janusz K., Nowak, Gabriel, Maes, Michael · 2017 · Molecular Neurobiology
186. Decreased plasma neuroactive amino acids and increased nitric oxide levels in melancholic major depressive disorder
     Yun-Rong Lu, Xinyan Fu, Ligen Shi, Yan Jiang, Juanli Wu, Xiao-Juan Weng, Zhao-Pin Wang, Xueyan Wu, Zheng Lin, Wei-Bo Liu et al. · 2014 · BMC Psychiatry
187. Increased levels of vascular endothelial growth factor in patients with major depressive disorder: A meta-analysis
     Ping‐Tao Tseng, Yu‐Shian Cheng, Yen‐Wen Chen, Ching-Kuan Wu, Pao‐Yen Lin · 2015 · European Neuropsychopharmacology
188. A pilot study of the phase angle between cortisol and melatonin in major depression – A potential biomarker?
     Theresa M. Buckley, Alan F. Schatzberg · 2009 · Journal of Psychiatric Research
189. Pharmacogenomics with Antidepressants in the STAR*D Study
     Eugene Lin, Po See Chen · 2008 · Pharmacogenomics
190. Elevated peripheral blood glutamate levels in major depressive disorder
     Masatoshi Inoshita, Hidehiro Umehara, Shin-ya Watanabe, Masahito Nakataki, M. Kinoshita, Y. Tomioka, A. Tajima, S. Numata, T. Ohmori · 2018 · Neuropsychiatric Disease and Treatment
191. Antioxidants Inhibit the Human Cortical Neuron Apoptosis Induced by Hydrogen Peroxide, Tumor Necrosis Factor Alpha, Dopamine and Beta-amyloid Peptide 1-42
     Sonia Medina, Marcos Martı́nez, Ángel Hernánz · 2002 · Free Radical Research
192. Dissociation of Learned Helplessness and Fear Conditioning in Mice: A Mouse Model of Depression
     Dominic Landgraf, Jaimie E. Long, Andre Der‐Avakian, Margo Streets, David K. Welsh · 2015 · PLoS ONE
193. Neuroendocrine aspects of primary endogenous depression XV: mathematical modeling of nocturnal melatonin secretion in major depressives and normal controls
     L. Kathleen Sekula, Joseph F. Lucke, Edwin Kevin Heist, R. Kenneth Czambel, Robert T. Rubín · 1997 · Psychiatry Research
194. Level of Thyroid-Stimulating Hormone (TSH) in Patients with Acute Schizophrenia, Unipolar Depression or Bipolar Disorder
     Adam Wysokiński, Iwona Kłoszewska · 2014 · Neurochemical Research
195. "Functional" or "psychosomatic" symptoms, e.g. a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression.
     Michael H. J. Maes · 2009 · PubMed
196. Proteomic Analysis of Serum from Patients with Major Depressive Disorder to Compare Their Depressive and Remission Statuses
     Jiyeong Lee, Eun-Jeong Joo, Hee–Joung Lim, Jong‐Moon Park, Kyu Young Lee, Arum Park, Ae Eun Seok, Hookeun Lee, Hee‐Gyoo Kang · 2015 · Psychiatry Investigation
197. Elevated C-reactive protein in depression: a predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy
     Harley, J., Luty, S., Carter, J., Mulder, R., Joyce, P. · 2010 · Journal of Psychopharmacology
198. Early life adversity and serotonin transporter gene variation interact to affect DNA methylation of the corticotropin-releasing factor gene promoter region in the adult rat brain
     Rick H. A. van der Doelen, Ilse A.C. Arnoldussen, Hussein Ghareh, Liselot van Och, Judith Regina Homberg, Tamás Kozicz · 2015 · Development and Psychopathology
199. Bias in Peripheral Depression Biomarkers
     Carvalho, André F., Köhler, Cristiano A., Brunoni, André R., Miskowiak, Kamilla W., Herrmann, Nathan, Lanctôt, Krista L., Hyphantis, Thomas N., Quevedo, João, Fernandes, Brisa S., Berk, Michael · 2016 · Psychotherapy and Psychosomatics
200. High-Affinity3H-lmipramine Binding: A new Biological Marker in Depression
     Salomón Z. Langer, E. Zarifian, Mike Briley, Rita Raisman‐Vozari, D. Sechter · 1982 · Pharmacopsychiatry